Raymond James & Associates Medpace Holdings, Inc. Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

A detailed history of Raymond James & Associates transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 55,689 shares of MEDP stock, worth $18.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
55,689
Previous 54,735 1.74%
Holding current value
$18.4 Million
Previous $22.5 Million 17.62%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
BUY
$320.58 - $457.29 $305,833 - $436,254
954 Added 1.74%
55,689 $18.6 Million
Q2 2024

Jul 19, 2024
BUY
$372.0 - $424.34 $2.36 Million - $2.69 Million
6,351 Added 13.13%
54,735 $22.5 Million
Q1 2024

Apr 22, 2024
BUY
$284.87 - $413.31 $391,696 - $568,301
1,375 Added 2.92%
48,384 $19.6 Million
Q4 2023

Jan 16, 2024
BUY
$227.52 - $312.68 $1.41 Million - $1.93 Million
6,177 Added 15.13%
47,009 $14.4 Million
Q3 2023

Oct 24, 2023
SELL
$233.98 - $281.67 $2.78 Million - $3.34 Million
-11,871 Reduced 22.52%
40,832 $9.89 Million
Q2 2023

Jul 25, 2023
SELL
$187.26 - $240.17 $164,601 - $211,109
-879 Reduced 1.64%
52,703 $12.7 Million
Q1 2023

Apr 14, 2023
SELL
$174.31 - $239.52 $165,943 - $228,023
-952 Reduced 1.75%
53,582 $10.1 Million
Q4 2022

Feb 08, 2023
SELL
$153.06 - $226.57 $3.96 Million - $5.87 Million
-25,888 Reduced 32.19%
54,534 $11.6 Million
Q3 2022

Oct 25, 2022
BUY
$145.13 - $182.49 $1.24 Million - $1.56 Million
8,562 Added 11.91%
80,422 $12.6 Million
Q2 2022

Aug 12, 2022
BUY
$130.2 - $168.03 $440,075 - $567,941
3,380 Added 4.94%
71,860 $10.8 Million
Q1 2022

May 11, 2022
BUY
$138.87 - $214.31 $3.85 Million - $5.94 Million
27,710 Added 67.97%
68,480 $11.2 Million
Q4 2021

Feb 08, 2022
BUY
$182.74 - $227.9 $219,288 - $273,480
1,200 Added 3.03%
40,770 $8.87 Million
Q3 2021

Nov 02, 2021
BUY
$170.18 - $198.21 $123,550 - $143,900
726 Added 1.87%
39,570 $7.49 Million
Q2 2021

Aug 11, 2021
BUY
$158.62 - $194.3 $119,599 - $146,502
754 Added 1.98%
38,844 $6.86 Million
Q1 2021

May 14, 2021
SELL
$132.02 - $168.26 $337,707 - $430,409
-2,558 Reduced 6.29%
38,090 $6.25 Million
Q4 2020

Feb 12, 2021
BUY
$109.38 - $149.19 $286,028 - $390,131
2,615 Added 6.88%
40,648 $5.66 Million
Q3 2020

Nov 04, 2020
SELL
$92.95 - $130.61 $155,970 - $219,163
-1,678 Reduced 4.23%
38,033 $4.25 Million
Q2 2020

Jul 28, 2020
BUY
$68.08 - $95.68 $1.54 Million - $2.16 Million
22,566 Added 131.62%
39,711 $3.69 Million
Q1 2020

Apr 21, 2020
BUY
$61.71 - $101.95 $304,415 - $502,919
4,933 Added 40.39%
17,145 $1.26 Million
Q4 2019

Feb 12, 2020
SELL
$70.08 - $84.64 $29,854 - $36,056
-426 Reduced 3.37%
12,212 $1.03 Million
Q3 2019

Nov 07, 2019
SELL
$62.38 - $85.89 $26,324 - $36,245
-422 Reduced 3.23%
12,638 $1.06 Million
Q2 2019

Aug 06, 2019
SELL
$53.64 - $65.42 $140,858 - $171,792
-2,626 Reduced 16.74%
13,060 $854,000
Q1 2019

May 06, 2019
SELL
$49.38 - $70.58 $301,119 - $430,396
-6,098 Reduced 27.99%
15,686 $925,000
Q4 2018

Feb 11, 2019
BUY
$46.97 - $63.98 $77,218 - $105,183
1,644 Added 8.16%
21,784 $1.15 Million
Q3 2018

Nov 14, 2018
BUY
$43.25 - $63.74 $871,055 - $1.28 Million
20,140 New
20,140 $1.21 Million
Q1 2018

May 14, 2018
SELL
$32.03 - $39.05 $752,769 - $917,753
-23,502 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$32.46 - $38.31 $35,608 - $42,026
1,097 Added 4.9%
23,502 $852,000
Q3 2017

Nov 13, 2017
SELL
$27.43 - $33.11 $1,453 - $1,754
-53 Reduced 0.24%
22,405 $715,000
Q2 2017

Aug 14, 2017
BUY
N/A
22,458
22,458 $651,000

Others Institutions Holding MEDP

# of Institutions
617
Shares Held
25.1M
Call Options Held
42.8K
Put Options Held
207K
View Full List

About Medpace Holdings, Inc.

MEDP Quotes by TradingView
  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.3B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email